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The tripeptide chains of the ergopeptines, a class
of pharmacologically important D-lysergic acid alka-
loid peptides, are arranged in a unique bicyclic cyclol
based on an amino-terminal a-hydroxyamino acid
and a terminal orthostructure. D-lysergyl-tripeptides
are assembled by the nonribosomal peptide synthe-
tases LPS1 and LPS2 of the ergot fungus Claviceps
purpurea and released as N-(D-lysergyl-aminoacyl)-
lactams. We show total enzymatic synthesis of
ergopeptines catalyzed by a Fe2+/2-ketoglutarate-
dependent dioxygenase (EasH) in conjunction
with LPS1/LPS2. Analysis of the reaction indicated
that EasH introduces a hydroxyl group into N-(D-
lysergyl-aminoacyl)-lactam at a-C of the aminoacyl
residue followed by spontaneous condensation
with the terminal lactam carbonyl group. Sequence
analysis revealed that EasH belongs to the wide
and diverse family of the phytanoyl coenzyme A
hydroxylases. We provide a high-resolution crystal
structure of EasH that is most similar to that of phy-
tanoyl coenzyme A hydroxylase, PhyH, from human.
INTRODUCTION
The term ‘‘cyclol’’ was coined by Wrinch to describe potential
cyclic peptide structures in proteins arising from formation of
covalent bonds between amide nitrogens and carbonyl groups
of neighboring peptide bonds with generation of tertiary hydroxyl
groups (Wrinch 1936, 1937). Although the cyclol concept for
proteins had to be abandoned later, cyclol structures have
indeed been found in a small number of microbial peptides
such as in the D-lysergic acid alkaloid peptides (ergopeptines)
(Hofmann, 1964). In these compounds, D-lysergic acid is
attached in amide linkage to a tripeptide chain arranged into
a bicyclic structure comprising a lactam ring and an oxazolidi-
none ring. The latter is formed by an ester bridge between an
a-hydroxyamino acid grouping in the first position and the termi-
nal orthoproline carboxyl group in the lactam ring, which carries,
in addition, a tertiary hydroxyl group (Hofmann, 1964) (Figures 1A
and 1B). Ergopeptines are notorious toxins produced by
ergot fungi having a long history as agents causing intoxications
in mammals, including humans, with symptoms known as
ergotism (Barger, 1931). On the other hand, they have been146 Chemistry & Biology 21, 146–155, January 16, 2014 ª2014 Elsevused as medicinal agents until today, based on the structural
similarity of the D-lysergic acid pharmacophore, with neuro-
transmitters such as dopamine, adrenaline, or serotonin
(Stadler and Giger, 1984; Berde and Stu¨rmer, 1978). The various
ergopeptines found in nature differ by substitutions of the
first two amino acid positions in the ergopeptine peptide
chains with similar nonpolar L-amino acids (Tudzynski et al.,
2001). The third position is nearly always occupied by L-proline
(Flieger et al., 1997).
Biosynthetic studies showed that the D-lysergyl-tripeptide
chains are assembled fromD-lysergic acid and their amino acids
via their D-lysergyl-mono- and -dipeptide intermediates by
the nonribosomal peptide synthetases LPS1 and LPS2 from
Claviceps purpurea (Riederer et al., 1996; Walzel et al., 1997).
In the in vitro conditions used, the D-lysergyl-tripeptides were
found to be released from LPS1 as N-(D-lysergyl-aminoacyl)-
lactams (L,L-ergopeptams) (Keller et al., 1988) (Figure 1C).
L,L-ergopeptams have the same amino acid arrangement and
stereoconfiguration as their corresponding ergopeptines, but
they lack the cyclol grouping. They are much less stable than
ergopeptines and in aqueous and slight alkaline conditions
epimerize to their L,D-ergopeptam isomers containing D-proline
instead of L-proline (Ott et al., 1963; Keller et al., 1988) (Fig-
ure 1C). Eventually, they undergo cleavage into the correspond-
ing D-lysergyl-amino acids and diketopiperazines (lactams)
(Ott et al., 1963; Stu¨tz et al., 1973). Different L,D-ergopeptams
containing valine in their first position were found in natural
alkaloid mixtures from C. purpurea (Flieger et al., 1997). The
existence of these L,D-ergopeptams led to speculations that
these were shunt products of the ergopeptine biosynthesis
that missed the oxygenation step in their peptide portions (Sta-
dler, 1982). In vivo incorporation studies of the oxygenation
step using 18O2 in cultures of C. purpurea indicated that the
cyclol oxygen bridge was derived from molecular oxygen but
not from water (Quigley and Floss, 1981). However, neither the
stage of peptide assembly at which the D-lysergyl peptide
chain became oxygenated nor the kind of enzyme that catalyzed
the reaction was clear.RESULTS AND DISCUSSION
Total Cell-Free Synthesis of Ergotamine and
Dihydroergotamine
To identify the step of introduction of oxygen into the D-lysergyl-
tripeptide backbone, cell extracts from a recently selected
ergotamine-producing strain of C. purpurea (strain D11)
(Havemann and Keller, 2011, German Society of Biochemistryier Ltd All rights reserved
Figure 1. Structure of Ergot Alkaloids and
Their Nonribosomal Assembly in Ergot
Fungi
(A) General structure of a cyclol.
(B) General structure of ergopeptines. The cyclol
connectivity is shaded as in (A). Naturally occurring
ergopeptine classes are classified by the amino
acid next to D-lysergic acid. R1 indicates methyl
(ergotamines), ethyl (ergoxines), and isopropyl
(ergotoxines). For R2, residues of nonpolar amino
acids are possible. Proline is constant.
(C) Nonribosomal assembly of D-lysergic acid tri-
peptides (shown ergotamine) catalyzed by LPS1/
LPS2. Assembly of D-lysergyl-tripeptide takes
place via the D-lysergyl-mono- and -dipeptides
on LPS1. Release of the D-lysergyl-tripeptide is
as N-(D-lysergyl-L-ala)-L-phe-L-pro-lactam (L,L-
ergotamam). In assay conditions, L,L-ergotamam
can isomerize into its L,D-ergotamam isomer
(Keller et al., 1988). A, adenylation domain; T,
thiolation domain; C, condensation domain; Cyc,
lactamization domain; C0, proximal domain.
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incubated with D-lysergic acid, alanine, phenylalanine, proline
(one of which was radiolabeled), and MgATP. Analysis of the re-
action products on thin-layer chromatography (TLC) revealed,
besides the formation of L,L-ergotamam and L,D-ergotamam,
the formation of an additional compound with the same migra-
tion (Rf) as authentic ergotamine (lane 1 in Figure 2A). This com-
pound was not formed when the cell-free extract had been
desalted prior to incubation (Figure 2A, lane 2), which pointed
to a low molecular weight cofactor promoting the formation of
the putative ergotamine.
Searching for cofactors revealed that ferrous iron (Fe2+ as
FeSO4) (Figure 2A, lane 5) in conjunction with 2-ketoglutarate
(2-KG) effectuated formation of the new compound with com-
plete disappearance of the two ergotamam bands normally
formed when Fe2+/2-KG is absent (Figure 2A, lanes 3 and 4).
Moreover, in anaerobic conditions, formation of the new com-
pound was drastically reduced, indicating that the reaction
was dependent on the presence of oxygen. Radiochemical
analysis of the enzymatically formed compound labeled
after incubation with 14C-phenylalanine or 14C-proline revealed
that it contained both phenylalanine and proline, respectively.Chemistry & Biology 21, 146–155, January 16, 2014In case of labeling with 14C-alanine, acid
hydrolysis of the compound yielded
14C-pyruvate in contrast to 14C-alanine-
labeled ergotamams, which yield exclu-
sively 14C-alanine. This strongly sug-
gested that the alanine residue in the
new compound was hydroxylated at its
a-C position. Cochromatography with
authentic ergotamine in different TLC
systems showed comigration of the
enzymatic product in each case. More-
over, adding dihydrolysergic acid instead
of D-lysergic acid to the enzyme incuba-
tions yielded a compound that behaved
like authentic dihydroergotamine, leavingno doubt that cell-free total synthesis of ergopeptines had been
accomplished.
Cyclolizing Activity Is Separable from Peptide
Synthetase Activity
To see whether the cyclolizing activity could be separated
from the ergotamam/dihydroergotamam-producing peptide
synthetases LPS1/LPS2, the cell extract was fractionated by
gel filtration on Superdex 75 (Figure S1 available online).
Complementation assays between fractions from the high and
the low fractionation range, Mr, of the column revealed that
the peak of ergotamine-forming activity was shifted to the
fractionation range behind the void volume, whereas the peak
of ergopeptam formation activity resided in the void volume.
This indicated that the oxygenase function was an enzyme
separate from LPS1/LPS2, having a smaller size than these.
EasH1, Candidate Gene for Cyclolizing Enzyme Activity
Inspection of the published gene sequence (Haarmann et al.,
2005) of the ergot alkaloid biosynthetic gene cluster from
C. purpurea ATCC 20102 revealed a gene, easH1, encoding
a protein, EasH (GenBank accession number AET79182.1), ofª2014 Elsevier Ltd All rights reserved 147
Figure 2. Biosynthesis of Ergopeptine Is Dependent on FeSO4/2-KG
and EasH
(A) Alkaloid peptide formation in nondesalted (lane 1) and desalted (lane 2) cell
extract. Formation of L,L- and L,D-ergotamams and ergotamine in desalted
cell extract without Fe2+/2-KG (lane 3), with 50 mM FeSO4 (lane 4), and with
50 mM FeSO4 and 25 mM 2-KG (lane 5). Reactions were performed as
described in the Supplemental Information. Radiolabel was 14C-alanine.
Reaction products were separated on a silica TLC plate (solvent system 2).
Autoradiography was for 4 days.
(B) At left, the expression and purification of EasH as an amino-terminal His6-
fusion protein is shown. The SDS-PAGE shows the purified enzyme after
Ni-NTA affinity chromatography and gel filtration on Superdex 200. At right,
alkaloid peptide formations catalyzed by LPS1/LPS2 dependent on EasH
are shown. Lane 1: Ergotamam formation catalyzed by LPS1/LPS2 in the
presence of 50 mM Fe2+/50 mM 2-KG and absence of EasH. Lane 2: the same
experiment but without Fe2+/2-KG and with 10 mg recombinant EasH. Lane 3:
the same experiment but with both Fe2+/2-KG and 10 mg recombinant EasH.
Reaction conditions, solvent system, and time of exposure to X-ray film are
same as in (A).
See also Figures S1 and S2.
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Cyclolization of Ergot Alkaloidscalculated mass of 35.4 kDa with high similarity to Fe2+/2-
KG-dependent dioxygenases, in particular, to a family called
phytanoyl coenzyme A (CoA) hydroxylases (Hausinger, 2004).
Phytanoyl CoA hydroxylases owe their name to their similarity
to the Fe2+/2-KG-dependent dioxygenase, PhyH, involved in
the catabolism of phytanic acid in humans, which hydroxylates
phytanic acid at its a position when activated as CoA thioester
(Mihalik et al., 1995, 1997). Nonheme dioxygenases show a
high degree of heterogeneity in their sequences, but all have in
common a Hx(D/E)xnH triad constituting the iron (II)-binding
site as part of the characteristic ‘‘jelly roll’’ motif of dioxygenases.
ClustalX analysis of the various dioxygenase protein sequences
distinguishes them in different subfamilies (Figure S2) that differ
in the length of the distance, n, between conserved residues in
the Hx(D/E)xnH consensus (Hogan et al., 2000; Hausinger,
2004). It is interesting that, while the sequence has highest
similarity to that of PhyH from human (McDonough et al.,
2005), such well-known dioxygenases such as isopenicillin148 Chemistry & Biology 21, 146–155, January 16, 2014 ª2014 ElsevN synthase (IPNS), deacetoxycephalosporin synthase (DAOCS),
and clavaminate synthase (CAS) (Zhang et al., 2000) catalyzing
specific ring closures in b-lactam ring formations belong to
families of dioxygenase sequences other than the phytanoyl
CoA hydroxylases (Figure S2). This and the obvious hetero-
geneity of sequences and structural diversity of substrates in
the phytanoyl CoA hydroxylase family initially precluded drawing
a conclusion about the possible mechanism of EasH. However,
since easH appeared to be the only functional gene in the
ergot alkaloid gene cluster encoding a Fe2+/2-KG-dependent
dioxygenase, we decided to express it heterologously and test
its gene product for whether it could catalyze ergopeptine syn-
thesis in conjunction with the peptide synthetases LPS1/LPS2.
EasH Catalyzes Ergotamine Synthesis in Conjunction
with LPS1/LPS2
The gene easH1 was PCR cloned from C. purpurea genomic
DNA, expressed as a soluble amino-terminal His6-fusion protein
in E. coli DH5a and purified to homogeneity (Figure 2B). Testing
the protein together with enriched LPS1/LPS2 (devoid of wild-
type dioxygenase activity) and all substrates necessary for
ergotamine synthesis showed that it effectuated ergotamine
synthesis in the same Fe2+/2-KG- (and dioxygen-)dependent
manner as that of the wild-type dioxygenase in the cell extract
(Figure 2B, right). This confirmed that easH encodes the cyclol-
izing dioxygenase of ergopeptine synthesis.
Properties of EasH
The cyclolization reaction was mainly characterized with wild-
type EasH using the cell extract from C. purpurea as source of
enzyme. There, LPS1/LPS2 and EasH could be tested together
or separately from each other simply either by omission of
Fe2+/2-KG (depletion of EasH) or by omission of ATP (depletion
of LPS1/LPS2) in the same system. We found that formations of
ergotamine and of ergotamams were tightly coupled to each
other with immediate and quantitative hydroxylation of the
D-lysergyl peptide when enough Fe2+/2-KG was present.
At 24C, both synthetic reactions proceeded equally high in
terms of radioactivity incorporated into product and linearly
with time for up to 10 min after which the rate gradually
decreased. Generally, addition of Fe2+ alone (25 mM and more)
led to inhibition of ergotamam formation to 50%–70%. However,
addition of 2-KG quickly re-established and stimulated the syn-
thetic capacity of the system to produce ergotamine with satura-
tion at 100 mM 2-KG and more. In contrast to a number of other
Fe2+/2-KG-dependent dioxygenases (Hausinger, 2004), neither
ascorbic acid nor added catalase stimulated the reaction.
Optima for both product formations were pH 8.0 and 24C. Gel
filtration of His6-EasH on a calibrated Superdex 200 column
revealed an Mr of 70,000 ± 2,000, suggesting that the native
protein is a dimer.
EasH Also Cyclolizes Ergoxine and Ergotoxine Groups
of Peptide Alkaloids
Incubation of the cell extract from C. purpurea with MgATP,
dihydrolysergic acid, phenylalanine, proline, and a-amino
butyric acid or valine as first position residue (instead of alanine)
resulted in the formation of the ergoxine dihydroergostine or the
ergotoxine dihydroergocristine, respectively. In case of omissionier Ltd All rights reserved
Figure 3. EasH Cyclolizes Dihydrolysergyl-ala-phe-pro-lactams to
Dihydroergotamine
Top: Lane 1 indicates conversion of purified radiolabeled L,L- and L,D-
dihydroergotamams to dihydroergotamine by recombinant EasH (50 mg) in
the presence of Fe2+/2-KG (50 mM). Lane 2 shows the same as in lane 1 butwith
the omission of Fe2+/2-KG. Lane 3 indicates conversion of purified labeled
L,L- and L,D-dihydroergotamams to dihydroergotamine by cell extract
(wild-type EasH) from C. purpurea (1.5 mg total protein) in the presence of
Fe2+/2-KG (50 mM). Lane 4 shows the same as lane 3 but with the omission
of Fe2+/2-KG. Bottom: Reaction scheme of the conversion. Radiolabeled
dihydroergotamam was prepared as described in the Supplemental Informa-
tion. Isolation and detection of reaction products was as described in Figure 2.
See also Figure S4.
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dihydroergostam or dihydroergocristam, were formed (Fig-
ure S3). This indicates that EasH can also hydroxylate amino
acids other than alanine, i.e., a-amino butyric acid or valine,
present in the first position of ergopeptines. Dihydroergostine
(88%) was formed in activity comparable to that of dihydroergot-
amine (100%). In contrast, the formation of dihydroergocristine
was much lower (10%) because C. purpurea strain D11 almost
exclusively produces ergotamine and therefore preferentially
expresses the ‘‘ergotamine-specific’’ LPS1 enzyme (Riederer
et al., 1996) (encoded by cpps1) in contrast to its ‘‘ergotoxine-
specific’’ paralogue LPS4 (encoded by cpps4) present in the
same strain (Haarmann et al., 2005, 2008). LPS1 activates valine
more weakly than alanine or aminobutyric acid (Walzel et al.,
1997). Therefore, the product formation rates of ergopeptines
reflect the substrate specificity of LPS1/LPS2 rather than that
of EasH. Nevertheless, the data clearly show that EasH can
cyclolize all three naturally occurring ergopeptine classes.
EasH Does Not Hydroxylate D-Lysergyl-Peptide
Intermediates Covalently Bound to LPS1
It was shown earlier that, during nonribosomal dihydroergota-
mam assembly, thioester-bound intermediates such as dihydro-
lysergyl-alanine (dihydrolysergyl-ala) and dihydrolysergyl-alanyl-
phenylalanine (dihydrolysergyl-ala-phe) accumulate on LPS1
when proline is omitted from the substrate mixtures (Walzel
et al., 1997). To test whether EasH hydroxylated intermediates
during assembly, the same experiments were performed
using the cell extract from C. purpurea D11 in the presence ofChemistry & Biology 21, 146Fe2+/2-KG. The analysis of LPS1-bound intermediates revealed
no hydroxylation. Moreover, attempts to demonstrate hydroxyl-
ation at the stage of dihydrolysergyl-tripeptide intermediate
(in the presence of all substrates) failed. In turnover conditions,
no intermediates accumulated on LPS1, regardless of when
Fe2+/2-KG was present or not. These circumstances precluded
determining whether the hydroxylation step takes place at
the stage of D-lysergyl-tripeptide while still covalently bound to
LPS1.
EasH Converts N-(dihydrolysergyl-ala)-phe-pro-lactam
into Dihydroergotamine
To address whether ergopeptams were substrates of EasH,
radiolabeled N-(dihydrolysergyl-ala)-phe-pro-lactam was syn-
thesized biosynthetically using the cell-free extract from
C. purpurea strain D11 with omission of Fe2+/2-KG. The com-
pound was isolated by solvent extraction from the reaction
mixture and, without further purification, directly incubated
either with recombinant EasH or with wild-type EasH and
Fe2+/2-KG. Figure 3 clearly shows that both wild-type EasH
and recombinant EasH converted dihydroergotamam and its
L,D isomer into dihydroergotamine.
Hofmann and coworkers showed that chemically synthesized
hydroxypropionyl-phe-pro-lactam (I) cyclolizes spontaneously
and quantitatively (Hofmann et al., 1963; Ott et al., 1963) (Fig-
ure 4). To clarify the mechanism, they prepared various model
hydroxyacyl- and hydroxyalkyllactams, e.g., hydroxypropionyl-
piperidone (II) or hydroxypropylpiperidone (III) (Figure 4). After
deprotection, the hydroxyacyllactam (II) cyclolized spontane-
ously, but the hydroxyalkyllactam (III) did not. Apparently, in
the diacylamide (imide) constellation of the hydroxyacyllactam
(II), the lactam carbonyl group is sufficiently activated to react
spontaneously with the alcoholic hydroxyl group (Griot and
Frey, 1963). In contrast, when there is a hydroxyalkyl instead of
a hydroxyacyl side chain, as in III, no imide structure is present
and the lactam carbonyl does not react. Since hydroxylation of
N-(D-lysergyl-ala)-phe-pro-lactam would lead to N-(D-lysergyl-
hydroxyala)-phe-pro-lactam, the D-lysergyl-homolog of I in
Figure 4, it has to be concluded that introduction of a hydroxyl
group into N-(D-lysergyl-aminoacyl)-lactams by EasH would
suffice to get subsequent spontaneous formation of the cyclol
(Figure 4) As yet, no hydroxylated N-(D-lysergyl-hydroxyami-
noacyl)-lactam could be detected.
The data in Figures 2 and 3 show that EasH converts
both stereoisomeric ergotamams (or dihydroergotamams) into
ergotamine/dihydroergotamine (Figure 3). However, it was not
clear whether one—and, if so, which one—of the two stereoiso-
mers was the preferred substrate. To shed more light on this,
the hydroxylation reaction was performed with wild-type
EasH under limitation of Fe2+/2-KG concentration (and, thus,
de facto under limitation of EasH in the reaction mixture). In
these conditions, the formed dihydroergotamams were not
quantitatively converted to dihydroergotamine, and it was
expected that, if one of the two stereoisomers would be prefer-
entially accepted by EasH, the other was left over. The results
obtained appear to confirm this expectation and indicate
that the L,L isomer could be cyclolized more rapidly than the
L,D isomer (Figure S4). In view of the single band representing
the ergotamine or dihydroergoamine formed in high Fe2+/2-KG–155, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 149
Figure 4. Cyclolization of Hydroxyacyllac-
tams Depends on the Activation of the
Lactam Carbonyl Group as Part of an Imide
Shown are reaction schemes illustrating the
different reactivities of hydroxypropionyl-(L-phe-
L-pro)-lactam (I), N-hydroxypropionyl-piperidone
(II), N-hydroxypropyl-piperidone (III), and N-(D-ly-
sergyl-hydroxyalanyl)-phenylalanyl-prolin lactam
(last line) to undergo cyclol formation. In the case
of N-hydroxypropyl-piperidone (III), the hydrox-
yalkyl analog of II, no cyclolization was observed
due to absence of the carbonyl group in the hy-
droxyacylside chain, whereas hydroxyacyllactam
(I) and (II) cyclolize spontaneously and quantita-
tively (data from Griot and Frey, 1963). N-(D-ly-
sergyl-hydroxylalanyl)-phenylalanyl-prolin lactam
was never observed during the work described
here, most probably due to its spontaneous
and immediate conversion to ergotamine after its
formation.
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sume that back-conversion of L,D isomer to L,L isomer takes
place and only the L-cyclol is formed. A kinetic character-
ization of the cyclolization reaction was not performed in
view of the instability and low quantities of the biosynthesized
substrate.
EasH Converts D-Lysergyl-Tripeptide-CoA or
-Pantetheine into Ergopeptines
From the data given above, it could still not be excluded that
EasH could hydroxylate D-lysergyl-tripeptide intermediates
bound as thioester to LPS1 before lactam ring formation
occurred. Previous chemical studies indicate that not only
chemically synthesized hydroxyacylpeptide lactams (Ott et al.,
1963) readily cyclolize spontaneously but also chemically syn-
thesized hydroxyacyldipeptide p-nitrophenylesters with carbox-
ylterminal prolines (Lucente et al., 1982). Logically, one could
conclude that LPS1 (Figure 1C) could lactamize not only thio-
ester-bound D-lysergyl-ala-phe-pro intermediate on its surface
but also D-lysergyl-hydroxyala-phe-pro intermediate originating
from hydroxylation by EasH. Since testing of hydroxylation of
D-lysergyl-tripeptide intermediates on the surface of LPS1 was
not possible, we prepared dihydrolysergyl-ala-phe-pro-CoA
thioester or -pantetheine thioester chemically and used them
as mimetic substrates for recombinant EasH.
In fact, when such peptide thioesters were incubated with
EasH, formation of a Fe2+/2-KG-dependent compound could
be detected. In the high-pressure liquid chromatography
(HPLC) separations, it had the same retention time as authentic
dihydroergotamine, and its mass spectrometric analysis150 Chemistry & Biology 21, 146–155, January 16, 2014 ª2014 Elsevier Ltd All rights reserverevealed a mass peak of [M+H]+ = 584
mass-to-charge ratio (m/z) consistent
with that of dihydroergotamine (Figure 6).
However, formation of that compound
was slow (requiring overnight conditions)
compared to the conversion by EasH of
N-(dihydrolysergyl-ala)-phe-pro-lactams
to dihydroergotamine, which took a fewminutes to be complete. Peptide thioesters are known to be
intrinsically reactive, and spontaneous terminal lactam ring for-
mation in peptides possessing ester-activated carboxyterminal
prolines have been described (Zanotti et al., 1983; Fischer,
2003). In fact, the analysis of reaction products formed in the in-
cubations of dihydrolysergyl-ala-phe-pro-CoA (or -pantetheine)
in the absence of EasH or Fe2+/2-KG showed that only dihy-
droergotamam had been formed (Figures 6B and 6C). In
contrast, when both EasH and Fe2+/2-KG were present, dihy-
droergotamam was not detectable, but dihydroergotamine in
appreciable yield was exclusively present. These data clearly
show that nonenzymatic lactamization of the dihydrolysergyl-tri-
peptide-CoA (and -pan) thioesters was the basis for the forma-
tion of dihydroergotamine in these incubations. When the
same experiments were performed with free dihydrolysergyl-
ala-phe-pro tripeptide, no formation of peptide lactam or
of dihydroergotamine was observed, confirming that carboxy-
terminal proline activation as thioester was necessary for
lactamization and that the presence of the lactam ring is the
prerequisite for the substrate recognition by EasH (see scheme
in Figure 5D).
We tested EasH also with the structurally related dihy-
drolysergyl-ala-leu-ala-CoA thioester, which represents the
sequence of the previously isolated unusual ergopeptine, ergo-
balansine, from Balansia species (Powell et al., 1990) containing
alanine in the third position instead of proline. However, the com-
pound did not lactamize spontaneously to the corresponding
dihydroergobalansam, nor was dihydroergobalansine formed
when EasH was present, showing that the presence of the
terminal proline in dihydrolysergyl-tripeptide thioster greatlyd
Figure 5. LC-MS Analysis of Reaction Prod-
ucts from Dihydrolysergyl-ala-phe-pro-CoA
in the Presence or Absence of EasH
(A–C) Dihydrolysergyl-ala-phe-pro-CoA (100 mg)
dissolved in buffer (total volume, 200 ml Tris-HCl,
pH 8.0) was incubated overnight: (A) with 10 mg
EasH and 50 mM Fe2+/2-KG, (B) in the same con-
ditions as in (A) but without EasH, and (C) in the
same conditions as in (A) but without Fe2+/2-KG.
(D) Depiction of the hypothetical reaction mecha-
nism of lactamization followed by cyclolization.
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amino acid like alanine.
In their biosynthesis, D-lysergyl-tripeptides are released from
LPS1 as peptide-lactamsmost probably by action of the carbox-
yterminal lactamization (Cyc) domain (Walzel et al.,1997; Correia
et al., 2003). The Cyc domain is similar in sequence and length
to the regular condensation (C) domains of nonribosomal
peptide synthetases (Bergendahl et al., 2002) but differs in its
C3 motif, QRxxxDG (Correia et al., 2003), from the canonical
C3 motif HHxxxDGxxS of C domains, which is responsible
for amino acid condensation (Bergendahl et al., 2002). The cata-
lytically important second His is replaced by an Arg, which inChemistry & Biology 21, 146–155, January 16, 2014analogy to C3 motifs of C domains, ab-
stracts a proton from the second amide
bond in the D-lysergyl-tripeptide interme-
diate on LPS1, enabling attack on to the
terminal proline thioester with release of
the ergopeptam (Figures 1C and 5D).
We expressed the Cyc domain of LPS1
as a soluble 55.1 kDa protein (see Sup-
plemental Information) and tested it
against dihydrolysergyl-ala-phe-pro-CoA
thioester in the presence or absence of
EasH. However, no stimulation of the
spontaneous formation of dihydroergota-
mam or dihydroergotamine (with EasH)
was observed. As yet, it is not clear
whether this Cyc domain standing alone
was inactive or whether the substrate
was not suitable.
Structure Determination of EasH
In order to get further insight into EasH,
crystals were grown from the amino-
terminal His6-tagged EasH protein. The
structure was solved by single anomalous
dispersion to 1.62 A˚ resolution (data,
phasing, and refinement statistics are
given in Tables S1 and S2 [Protein Data
Bank entry 4NAO]). Aside from disor-
dered regions near the amino- and
carboxy-terminus and extended loop re-
gions, the structure could be completely
modeled (Table S3). In the asymmetric
unit, we could locate one EasH molecule.
The dimeric architecture of the proteinis complemented by a symmetry-related EasH molecule, in
agreement with the determined Mr in solution that indicated a
dimeric structure of the protein (Figure 6A). The total surface
area involved in dimer formation is 2,740 A˚2.
The structure of EasH contains a mixed a/b-fold composed
of a major and a minor b sheet that fold into a double-stranded
b-helix (DSBH), or jelly-roll fold, characteristic for the family of
Fe2+/2-KG-dependent oxygenases (Hausinger, 2004). The ma-
jor and minor b sheets consist of four b strands each (b4, b11,
b6, and b9; and b5, b10, b7, and b8, respectively) (Figure S5).
Three additional b strands (b1, b2, and b3) and six a helices
arrange around the DSBH fold. A Dali (Holm and Rosenstro¨m,ª2014 Elsevier Ltd All rights reserved 151
Figure 6. Structure of EasH
(A) Dimeric arrangement of the EasH protein in cartoon representation. 2-KG is
represented by yellow sticks, and Fe2+ is represented by an orange sphere.
The carboxy-terminal dimerization domain is drawn in magenta.
(B) Superposition of EasH (green) and PhyH (gray).
(C) Interactions of 2-KG, drawn in stick representation. Red, dashed lines
indicate hydrogen bonds. Gray lines represent the octahedral coordination
of Fe2+.
See also Figures S5 and S6 and Tables S1–S3.
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Cyclolization of Ergot Alkaloids2010) search revealed that the structure of EasH closely resem-
bles phytanoyl CoA hydroxylase PhyH (McDonough et al.,
2005) and its homolog PhyHD1 (Zhang et al., 2011), both
from human with a root-mean-square deviation of 2.3 A˚2 for
163 pairs of Ca atoms (Figure 6B). The overall arrangement
of the central DSBH motif is highly similar between the two
structures, whereas major differences can be detected in the
loop regions or additional domains. The most striking difference
is in the carboxy-terminal region of EasH that folds in a distinct
domain comprising a short a-helical element and a b-hairpin
formed by b12 and b13 but is absent in PhyH (McDonough
et al., 2005). This carboxy-terminal domain is involved in the
dimerization of EasH (Figure 6A), whereas PhyH is a monomer
(McDonough et al., 2005). In the case of the dimeric 2-KG-
dependent dioxygenase factor-inhibiting hypoxia-inducible fac-
tor (FIH), the dimeric state is prerequisite for enzymatic activity
(Lancaster et al., 2004). Like in EasH, in FIH, the dimerization
region (represented by an a helix) is also located at the car-
boxy-terminus and was shown to form part of the substrate
binding site. As yet, it is not clear whether the dimeric state
of EasH is prerequisite for its catalytic activity. For the mono-
meric PhyH, a large groove extending from the carboxy-termi-
nal helix to the iron-(II)-binding site was identified as a potential
pocket with a size fitting that of the phytanoyl CoA substrate
(McDonough et al., 2005).152 Chemistry & Biology 21, 146–155, January 16, 2014 ª2014 ElsevIn the experimental electron density, we could clearly identify
the ferrous iron; in addition, there was electron density for 2-KG
(Figure S6). Even though the crystallization experiment was
performed under aerobic conditions, EasH could accumulate
and retain the ferrous iron and 2-KG during expression and
purification. Judged from the s level of the electron density, we
assume that the two cofactors are not fully occupied, resulting
in an occupancy of about 80%. Fe2+ is octahedrally coordinated
by the amino acid residues of the catalytic triad His141, Asp143,
and His217; a water molecule; and in a bidentate manner by
the 2-oxoacid group of 2-KG (Figure 6C). The b10 strand had
a distorted backbone conformation at amino acid 139 and 140.
This is of functional importance, because it allows the backbone
carbonyl of Lys139 to establish a hydrogen bond to His141,
thereby rigidifying the orientation of its imidazole ring for Fe2+
ligation. This unusual conformation is further stabilized by
Trp140 establishing a p-stacking interaction with the guanidi-
nium group of Arg218 on the b5 strand, the neighboring amino
acid of the other Fe2+-coordinating amino acid His217 (Figure 6).
Compared to the structure of PhyH (McDonough et al., 2005)
the C50-carboxylate function of 2-KG is oriented toward b7
strand points deeper into the central DSBH fold. The 2-KG of
EasH is forced into this conformation by the presence
of Phe164 and Phe170. Additionally, the equivalent residue of
Phe164 of EasH is Trp181 of PhyH, which establishes a
hydrogen bond from its indole function to the C50-carboxylate
of 2-KG. In the structure of EasH, the C50-carboxylate of 2-KG
establishes a hydrogen bond to the guanidinium function of
Arg228 (Figure 6C). The side chain of latter residue occurs in a
double conformation reflecting the partial occupancy of 2-KG
and Fe2+. The C50-carboxylate is additionally hydrogen bonded
to the hydroxyl of Thr177 residing on the b7 strand of the
DSBH fold similar to clavaminate synthase CAS (Zhang et al.,
2000) but contrasting the arrangement in PhyH where the C50-
carboxylate is hydrogen bonded to Ser266 on the b5 strand
(McDonough et al., 2005). In contrast to PhyH, we could not
detect a hydrogen bond from Arg86 (Lys120 in PhyH) to the
C10-carboxylate.
For PhyH, as well as for its highly similar homolog PhyHD1, it
has been postulated that the flexible disordered loops surround-
ing the active site play a role in substrate binding and may only
become ordered in the presence of the substrate phytanoyl
CoA (McDonough et al., 2005). In the case of EasH, there is
only one loop segment, in close proximity of the active site that
could not have been modeled due to its flexibility. The binding
pocket of EasH is similarly located as in PhyH, characterized
by a large groove with approximate dimensions of 13 3 35 A˚
(Figure S6). The cavity is large enough to accommodate a
substrate molecule such as ergotamam or dihydroergotamam.
In the walls of the cavity, there are a number of aromatic residues
lining the active site that might be important to stabilize the
aromatic ring system of the D-lysergic acid moiety of ergopep-
tams. On the other hand, there are numerous side-chain
residues that could function as hydrogen bonding donors or
acceptors. Additionally, there is a loop that could not bemodeled
due to its flexibility but that potentially becomes folded upon
substrate binding. We could detect ill-defined, bulky electron
density in 2FoFc and FoFc electron density maps at a length of
about 8 A˚ at s = 1.0 that could not be interpreted. This patchier Ltd All rights reserved
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from Fe2+. Cocrystallization experiments were performed with
dihydrolysergyl-ala-phe-pro-CoA in the hope that spontane-
ously formed N-(dihydrolysergyl-alanyl)-phe-pro-lactam could
complex to the enzyme. However, no cocrystals were obtained,
apparently due to the lability of the acyl-lactam that, in aqueous
milieu, gradually decomposes to dihydrolysergyl-ala and phe-
pro diketopiperazine.
Conclusions
The data presented here set another example for the role of
nonheme dioxygenases in the final steps of the biosyntheses
of important peptide-based natural compounds such as the
b-lactams, carbapenams, and clavams in which thiazolidine,
dihydrothiazine, pyrrolidine, or oxazolidine rings are fused to
b-lactam rings (Demain and Elander, 1999). As in the case of
the ergopeptines, these compounds are derived from tri- and
dipeptide precursors such as aminoadipoyl-cysteinyl-D-valine
for b-lactams such as penicillins and cephalosporins or, e.g.,
deoxyguanidino proclavaminic acid for clavams by action of
nonheme dioxygenases (Demain and Elander, 1999). However,
these dioxygenases catalyze more than one oxygenating or H-
abstracting step and, in the case of penicillins/cephalosporins,
are responsible for formation of both rings in their structures
(Kershaw et al., 2005). It is interesting that CAS—like EasH—cat-
alyzes formation of an oxazolidinine ring fused to a b-lactam ring,
which resembles oxazolidinine ring formation catalyzed by cyclol
synthase. However, the mechanisms of this ring condensation
is different and proceeds via hydrogen abstraction from the
b-lactam ring, enabling attack of an hydroxyl group previously
introduced by CAS itself into the side chain of the clavaminate
precursor (Townsend, 2002). In contrast, in case of cyclolization
of ergopeptines, the introduction of the hydroxyl group into
N-(D-lysergyl-aminoacyl)-lactam by EasH seems to be per se
sufficient to induce subsequent spontaneous ring formation
because the prolyl carbonyl in the ‘‘a’’-lactam ring is activated
through the imide structure of the hydroxyacyllactam.
SIGNIFICANCE
We dissected a total synthesis system of ergopeptine
biosynthesis from the ergot fungusClaviceps purpurea con-
sisting of the nonribosmal peptide synthetases LPS1/LPS2
and EasH, a Fe2+/2-KG-dependent dioxygenase. Analysis
of the reaction sequence reveals that LPS1/LPS2 synthesize
N-(D-lysergylaminoacyl)-lactams from D-lysergic acid and
the three amino acids and that EasH hydroxylates these lac-
tams at a-C of the amino acid adjacent to D-lysergic acid.
In the resultant N-(D-lysergyl-hydroxyaminoacyl)-lactam,
condensation of the alcoholic peptide hydroxyl group with
the carboxyterminal prolyl peptide carbonyl group in the lac-
tam ring creates the orthostructure characteristic for the
cyclol combining ester and peptide bonds with the presence
of a tertiary hydroxyl group. From the known behavior of
synthetic model hydroxyacyllactams, it is concluded that
the condensation step after hydroxylation is spontaneous
due to high reactivity of the prolyl carbonyl, which is prereq-
uisite for the reaction with the alcoholic peptide hydroxyl
group. Accordingly, EasH converts dihydrolysergyl-tripep-Chemistry & Biology 21, 146tide-CoA and -pantetheine thioesters only after their prior
slow spontaneous conversion to dihydrolysergyl peptide
lactams, which shows that the lactam structure is prerequi-
site for the hydroxylation step. Determination of the 3D
structure of EasH shows that it has high similarity to phyta-
noyl coenzyme A hydroxylase, PhyH, from human.
EXPERIMENTAL PROCEDURES
Strains and Cultures
Claviceps purpurea strain D11was selected fromClaviceps purpurea strain D1
(Havemann and Keller, 2011, German Society of Biochemistry and Molecular
Biology, Ann. Meeting, conference abstract). It was grown and maintained as
described elsewhere (Keller et al., 1988). E. coli strain DH5a (Hanahan, 1983)
was used for cloning and expression of easH1.
Chemicals
D-lysergic acid and dihydrolysergic acid were kindly provided by
Drs. J.-J. Sanglier and F. Petersen (Novartis AG). All other chemicals relevant
for this work are listed in the Supplemental Information.
Cell Extract from C. purpurea
Cell extract containing both LPS1/LPS2 and EasH were obtained by passing
mycelium suspended in extraction buffer twice through a French pressure
cell at 20,000 psi. After centrifugation, supernatant (containing 5–10 mg/ml
protein) were desalted on a PD-10 column and served as the source for the
total cell-free system of ergopeptine synthesis. In several instances, the cell
extract was further concentrated by adsorption to DEAE-cellulose and subse-
quent elution with salt. This was followed by ammonium sulfate precipitation
(70% saturation). Protein was collected by centrifugation and frozen as pellets
at 80C and could be stored for months. As necessary, thawed precipitates
were dissolved in a minute volume of buffer and desalted as described earlier.
Details are described in the Supplemental Information.
Cloning and Expression of eash1 from C. purpurea
The gene easH1 (accession number AET79182.1) was ligated as BamHI/
HindIII fragment to BamHI/HindIII-cleaved expression vector pQE80
(QIAGEN), resulting in plasmid easH_pQE80. For this, the DNA region between
nucleotides 35947 and 36891 of the ergot alkaloid biosynthesis gene cluster
of C. purpurea (GenBank accession number JN186799) was amplified with
primers easH_for 50-CATGGATCCAAAATGACTTC and easH_rev 50-AACC
AAAGCTTTACGCTACACAG using genomic DNA from C. purpurea strain
D11 as template. The resultant fragment was cloned using plasmid pJET1.2/
blunt (Fermentas/Thermo Scientific) from which the easH gene was cut out
with BamHI/HindIII. Plasmid eash_pQE80 was transformed to E. coli DH5a.
Growth was in lysogeny broth medium at 37C up to an optical density of
A600 = 0.6 and then at 16
C with addition of 1 mM IPTG for a further 20 hr.
Preparation of Recombinant EasH
His6-EasHwas prepared from E. coli transformedwith easH-pQE80 by Ni-NTA
affinity techniques according to the manufacturer’s (QIAGEN) protocols. The
eluate from the Ni-NTA column (1.6–1.8 ml) was passed through a Superdex
200 column that delivered a main protein peak at around fraction 70 (corre-
sponding Mr of 70,000) mainly representing EasH. Purified protein (26 mg;
95% purity in SDS-PAGE) was obtained from 2 l of culture. Protein suitable
for crystallization was obtained by two further rounds of purification involving
gel filtration on Superdex 75 and ion exchange chromatography on MonoQ.
Enzyme Assays
Cell-free ergopeptam synthesis was performed with the cell extract or con-
centrated enzyme from C. purpurea in essentially the same conditions as
described elsewhere (Riederer et al., 1996; Walzel et al., 1997; Keller et al.,
1988). Ergopeptine synthesis was in the additional presence of FeSO4 and
2-KG. Further details see in the Supplemental Information. EasH was tested
either in conjunction with LPS1/LPS2 (devoid of wild-type EasH activity)
purified by Superdex 75 gel filtration of cell extract (1–2 mg protein) or directly
with ergopeptams or dihydrolysergyl-ala-phe-pro-CoA or -pan thioesters at–155, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 153
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were isolated and separated as described elsewhere (Riederer et al., 1996;
Walzel et al., 1997). Dihydrolysergyl-peptide intermediates covalently bound
to LPS1 were isolated from LPS1-substrate complexes as described else-
where (Walzel et al., 1997). For further details, see the Supplemental
Information.
Methods of Analysis
The various methods necessary for extraction, separation, and analysis of
enzymatically formed radiolabeled peptide alkaloids are essentially the same
described in previous work (Keller et al., 1988). Specific details of the analysis
in the context of the work described here are given in the Supplemental
Information. Mass spectrometric determinations were performed on an
Exactive Orbitrap liquid chromatography/mass spectrometry (LC/MS) from
Thermo Scientific. The column was a Hypersil GOLD 50 3 2.1 mm, 5 mm
particle size (Thermo Scientific), run with a water-acetonitrile gradient
(with 0.1% formic acid) from 5%–100% acetonitrile.
Syntheses
Synthesis of dihydrolysergyl-peptides was based on previous work in our
laboratory (Walzel et al., 1997). Generally, dihydrolysergic acid was activated
as chloroformiate and reacted with ala-phe-pro or various other peptides in
the presence of Hu¨nig’s base. The resultant dihydrolysergyl-peptides were
purified by HPLC and used as reference material for the identification of
enzymatically formed products and intermediates. Dihydrolysergyl-tripeptide
CoA and pan thioesters were prepared by standard procedures (see Supple-
mental Information).
Bioinformatic Analysis
Alignment of protein sequenceswas performed by using ClustalX2 (Thompson
et al., 1997). High-scoring BLASTP (National Center for Biotechnology Infor-
mation) hits to the EasH sequence were used to construct trees (Dereeper
et al., 2008).
Crystallization and Cooling
EasH was crystallized at a protein concentration of 32 mg/ml in a buffer
composed of 20 mM Tris-HCl, pH 7.5, 150 mM NaCl. Crystallization experi-
ments were performed in a hanging-drop set-up at 291 K. Crystals appeared
after 1 day over a reservoir solution composed of 40% (v/v) polyethylene
glycol 600 and 125 mM Na3 citrate at pH 5.6. With no further need of a
cryoprotectant, the crystals were flash cooled in liquid nitrogen.
Phasing and Refinement
Synchrotron diffraction data were collected at the beamline 14.2 of the MX
Joint Berlin laboratory at the Berliner Elektronenspeicherring-Gesellschaft
fu¨r Synchrotronstrahlung (BESSY) or beamline 14.1 of Petra III. X-ray data
collection was performed at 100 K. Diffraction data were processed with
the XDS package (Kabsch, 2010). The structure of EasH was solved by single
anomalous dispersion data with phase information to 2.6 A˚ resolution. The
Fe2+ and five sulfur positions could be located, determined, refined, and
used for phasing in SHARP (Vonrhein et al., 2007) (Tables S1 and S2). An
initial model was built with AUTOBUILD (Terwilliger, 2004; Terwilliger et al.,
2008) as implemented in PHENIX (Adams et al., 2010); subsequently, the
phases were extended to the high resolution limit of 1.62 A˚. For calculation
of the free R-factor, a randomly generated set of 5% of the reflections
from the diffraction data set was used and excluded from the refinement.
The structure was initially refined by applying a simulated annealing protocol
and in later refinement cycles merely by maximum-likelihood restrained
refinement as implemented in PHENIX_REFINE (Afonine et al., 2012),
followed by iterative model building cycles with COOT (Emsley et al.,
2010). Water molecules were picked with COOT and manually inspected.
Model quality was evaluated with PROCHECK (Laskowski et al., 1993) and
MolProbity (Chen et al., 2010). Secondary structure was analyzed with
DSSP (Kabsch and Sander, 1983). ALSCRIPT (Barton, 1993) was used
to draw secondary structure. Figures were prepared using PyMOL (DeLano,
2002).154 Chemistry & Biology 21, 146–155, January 16, 2014 ª2014 ElsevSUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and three tables and can be found with this article online at
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